Assessment of MDD Management in Andalusia (PismaEP)

August 12, 2014 updated by: AstraZeneca

Assessment of MDD Management Strategies in Andalusia: A Sub-analysis of the PismaEP Study

The main objectives of this study are to describe medical professionals responsible of the management of patients with MDD in a representative region of Andalusia (in terms of type of sites managing the disease, and referral to SC criteria); Describe MDD patient characteristics at inclusion in the PISMA-Ep Study; and to evaluate those factors associated to a higher incidence of referral from PC to SC.

Study Overview

Status

Completed

Conditions

Detailed Description

Assessment of MDD management strategies in Andalusia: A Sub-analysis of the PismaEP Study

Study Type

Observational

Enrollment (Actual)

5309

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Granada, Spain
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

MDD patients treated in Primary Care or Secondary Care in the Region of Granada and recruited for the PISMA-Ep Study

Description

Inclusion Criteria:

  • MDD Diagnosis Participants of the PismaEP study 18 yo. or older

Exclusion Criteria:

  • No specific exclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
1

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of Visits to Primary Care
Time Frame: From Jan 2010 to Jan 2011
From Jan 2010 to Jan 2011
Number of Visits to Secondary Care
Time Frame: From Jan 2010 to Jan 2011
From Jan 2010 to Jan 2011
Number of Referrals
Time Frame: From Jan 2010 to Jan 2011
From Jan 2010 to Jan 2011

Secondary Outcome Measures

Outcome Measure
Time Frame
Demographics
Time Frame: From Jan 2010 to Jan 2011
From Jan 2010 to Jan 2011
Type of site
Time Frame: From Jan 2010 to Jan 2011
From Jan 2010 to Jan 2011
Type of therapeutic strategy
Time Frame: From Jan 2010 to Jan 2011
From Jan 2010 to Jan 2011
Type of disease
Time Frame: From Jan 2010 to Jan 2011
From Jan 2010 to Jan 2011
Severity of disease
Time Frame: From Jan 2010 to Jan 2011
From Jan 2010 to Jan 2011

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Principal Investigator: Jorge Cervilla, MD, Hospital San Cecilio

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Actual)

September 1, 2013

Study Completion (Actual)

September 1, 2013

Study Registration Dates

First Submitted

January 12, 2012

First Submitted That Met QC Criteria

January 17, 2012

First Posted (Estimate)

January 18, 2012

Study Record Updates

Last Update Posted (Estimate)

August 13, 2014

Last Update Submitted That Met QC Criteria

August 12, 2014

Last Verified

August 1, 2014

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • NIS-NES-XXX-2011/3
  • PismaEP

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on MDD Management Strategies

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe